{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T07:10:50Z","timestamp":1773645050337,"version":"3.50.1"},"reference-count":6,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp;amp; Cancer"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1002\/pbc.31081","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T11:41:19Z","timestamp":1715859679000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Practical challenges associated with efanesoctocog alfa (ALTUVIIIO) prophylaxis in a 19\u2010month\u2010old male with severe hemophilia A"],"prefix":"10.1002","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9967-5304","authenticated-orcid":false,"given":"Jessica N.","family":"Mistretta","sequence":"first","affiliation":[{"name":"Bleeding &amp; Clotting Disorders Institute, Dills Family Foundation Center for Research at BCDI Peoria Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria G.","family":"Espa\u00f1ol","sequence":"additional","affiliation":[{"name":"Bleeding &amp; Clotting Disorders Institute, Dills Family Foundation Center for Research at BCDI Peoria Illinois USA"},{"name":"Departments of Pediatrics and Medicine University of Illinois College of Medicine at Peoria  Peoria Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Tarantino","sequence":"additional","affiliation":[{"name":"Bleeding &amp; Clotting Disorders Institute, Dills Family Foundation Center for Research at BCDI Peoria Illinois USA"},{"name":"Departments of Pediatrics and Medicine University of Illinois College of Medicine at Peoria  Peoria Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dane C.","family":"Christ","sequence":"additional","affiliation":[{"name":"Bleeding &amp; Clotting Disorders Institute, Dills Family Foundation Center for Research at BCDI Peoria Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen D.","family":"Jones","sequence":"additional","affiliation":[{"name":"Bleeding &amp; Clotting Disorders Institute, Dills Family Foundation Center for Research at BCDI Peoria Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9415-9543","authenticated-orcid":false,"given":"Jonathan C.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Bleeding &amp; Clotting Disorders Institute, Dills Family Foundation Center for Research at BCDI Peoria Illinois USA"},{"name":"Departments of Pediatrics and Medicine University of Illinois College of Medicine at Peoria  Peoria Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"e_1_2_1_6_2_1","doi-asserted-by":"publisher","DOI":"10.1542\/pir.2020-004143"},{"key":"e_1_2_1_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14046"},{"key":"e_1_2_1_6_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002699"},{"key":"e_1_2_1_6_5_1","unstructured":"Bioverativ Therapeutics Inc.Efanesoctocog alfa [antihemophilic factor (recombinant) Fc\u2010VWF\u2010XTEN fusion protein\u2010ehtl]: US prescribing information.Bioverativ Therapeutics Inc;2023."},{"key":"e_1_2_1_6_6_1","doi-asserted-by":"crossref","unstructured":"MalecL PeyvandiF ChanAKC et\u00a0al.Efanesoctocog alfa prophylaxis for previously treated patients <12 years of age with severe hemophilia A. ISTH 2023 Congress; June 24\u201328 2023. Abstract LB01.1.","DOI":"10.1016\/j.rpth.2023.100288"},{"key":"e_1_2_1_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14831"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.31081","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pbc.31081","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.31081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T06:38:52Z","timestamp":1773643132000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.31081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":6,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1002\/pbc.31081"],"URL":"https:\/\/doi.org\/10.1002\/pbc.31081","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"assertion":[{"value":"2024-03-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e31081"}}